Of these, glutamyl-prolyl-tRNA synthetase (EPRS) was up-regulated and was related to poor clinical outcomes in breast cancer, suggesting that EPRS might be regulated by DNA methylation and contributed to the development of breast cancer (Qi et al., 2019). The gene discussed is EPRS1; the disease is breast carcinoma.